(4S,5R,8R,9S,10S,11R,12R,14R)-11-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-5-ethyl-9-hydroxy-2,4,8,10,12,14-hexamethyl-6,15,16-trioxatricyclo[10.2.1.11,4]hexadec-2-en-7-one; 3-O-De(2,6-dideoxy-3-C-methyl-3-O-methyl-?-L-ribo-hexopyranosyl)-10,11-didehydro-9-deoxo-6,11,12-trideoxy-6,9:9,12-diepoxy-erythromycin; 6,15,16-Trioxatricyclo[10.2.1.11,4]hexadecane Erythromycin Derivative; Erythralosamine
Erythromycin EP Impurity I is a fully characterized chemical compound used as a reference standard of API Erythromycin. The standard offered is compliant with regulatory guidelines. Erythromycin EP Impurity I is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 546-57-6
Related products
Erythromycin Impurity J (Roxithromycin EP Impurity C)
M.F.
M.W. 748.95
CAT# AR-E01801
CAS# 111321-02-9
Erythromycin EP Impurity E (Erythromycin A Enol Ether)
M.F.
M.W. 715.92
CAT# AR-E01814
CAS# 33396-29-1
2’,4’’-O-Bis(trimethylsilyl)-6-O-methylerythromycin A 9-[O-(1- methoxy-1-methylethyl) Oxime
M.F.
M.W. 979.45
CAT# AR-E01831
CAS# 119699-81-9
